Royalty Rates for Pharmaceuticals & Biotechnology features more
real-deal royalty rates, license fees, and milestone payment benchmarks
than any other publication.

The eighth edition of Royalty Rates for Pharmaceuticals & Biotechnology
contains hundreds of royalty rates and other financial compensation
benchmarks that can be used to optimize the pricing of biotechnology and
pharmaceutical innovations. You'll find updated and expanded information
from past editions as well as an increased number of reported license
agreements. This new edition and the transaction details have been
collected from well-established sources over a period of 22 years of
research.

Royalty Rates for Pharmaceuticals & Biotechnology provides real-deal
information for hundreds of transactions, including the technology
licensed, royalty rates, license fees, and milestone payments. And it
goes well beyond the rates to provide context for each deal analyzed.
This unique resource is organized into two useful sections:

The second section of this one-of-a-kind report presents detailed
financial information from real-world transactions. You'll find
information on the parties involved in the transactions along with a
description of the technology exchanged and all financial details that
could be discovered.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her
physician.